Paulson & Co Portfolio holdings
Paulson & Co. is the investment firm John Paulson, its founder and president, started in 1994 and ran as a hedge fund, which made its name with a 2007 bet against the subprime mortgage market. For that bet, it bought credit default swaps, a form of insurance on debt that it did not own. It focused on mergers, event-driven trades and credit, buying undervalued takeover targets and pushing as a large shareholder for higher bids. Since 2020 it has been a family office that invests Paulson's own money.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.54B |
| 2 |
HOT
Starwood Hotels & Resorts Worldwide
HOT
|
+$1B |
| 3 |
Viatris
VTRS
|
+$492M |
| 4 |
AGN
Allergan plc
AGN
|
+$457M |
| 5 |
BRCM
Broadcom
BRCM
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLXP
Salix Pharmaceuticals
SLXP
|
+$950M |
| 2 |
TLM
Talisman Energy
TLM
|
+$537M |
| 3 |
HMHC
Houghton Mifflin Harcourt
HMHC
|
+$463M |
| 4 |
SHPG
Shire
SHPG
|
+$306M |
| 5 |
MNK
Mallinckrodt
MNK
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.37% |
| 2 | Communication Services | 14.58% |
| 3 | Miscellaneous | 9.92% |
| 4 | Real Estate | 6.87% |
| 5 | Technology | 6.16% |
Similar funds
Paulson & Co's Q2 2015 Portfolio in Review
As of Q2 2015, Paulson & Co held 68 positions worth $21.7B, up 10% from $19.6B the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Paulson & Co deployed $1.12B of net new capital in Q2 2015, opening 7 new positions and adding to 15 existing holdings. Its largest new stake was Starwood Hotels & Resorts Worldwide: 11,999,400 shares worth $973M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 36% a quarter earlier, followed by Communication Services and Miscellaneous.
On the sell side, the largest reduction was Houghton Mifflin Harcourt, an estimated $463M trimmed.
- Paulson & Co's largest Q2 2015 buy was Starwood Hotels & Resorts Worldwide: 11,999,400 shares worth $973M.
- Paulson & Co added most to Bausch Health in Q2 2015, an estimated $1.54B increase.
- Paulson & Co's biggest Q2 2015 reduction was Houghton Mifflin Harcourt, cutting an estimated $463M.
- Paulson & Co fully exited Salix Pharmaceuticals in Q2 2015, selling an estimated $950M.
- Paulson & Co's ten largest holdings make up 63% of its $21.7B portfolio in Q2 2015.
- Paulson & Co opened 7 new positions and closed 7 in Q2 2015.
- Paulson & Co's portfolio value rose 10% quarter-over-quarter to $21.7B.
Based on Paulson & Co's 13F filing for Q2 2015, filed 14 Aug 2015.